Sepsis: New Insights, New Therapies, Novartis Foundation Symposium / Edition 1

Sepsis: New Insights, New Therapies, Novartis Foundation Symposium / Edition 1

by Novartis Foundation
     
 

ISBN-10: 0470027983

ISBN-13: 9780470027981

Pub. Date: 04/09/2007

Publisher: Wiley

Sepsis: New Insights, New Therapies brings together contributions from an international group of experts in diverse fields to consider how the various pathways implicated in early and late sepsis interact, with a particular emphasis on novel concepts and potential new therapeutic approaches. Topics covered include adaptive immunity, inflammation,

…  See more details below

Overview

Sepsis: New Insights, New Therapies brings together contributions from an international group of experts in diverse fields to consider how the various pathways implicated in early and late sepsis interact, with a particular emphasis on novel concepts and potential new therapeutic approaches. Topics covered include adaptive immunity, inflammation, neuroendocrinology, bioenergetics, and metabolism.

Product Details

ISBN-13:
9780470027981
Publisher:
Wiley
Publication date:
04/09/2007
Series:
Novartis Foundation Symposia Series, #194
Pages:
302
Product dimensions:
6.36(w) x 9.31(h) x 0.79(d)

Table of Contents

Symposim on Sepsis: new insights, new therapies, held at the Novartis Foundation, London, 14-16 February 2006.

Editors: Derek J. Cahdwick (Organizer) and Jamie Goode.

This Symposim was based on a proposal made by Mitchell Fink and Mervyn Singer.

Chair’s introduction (Mitchell P. Fink).

Discussion.

Strategies to modulate cellular energetic metabolism during sepsis (Alessandro Protti and Mervyn Singer).

Discussion.

Immunostimulation is a rational therapeutic strategy in sepsis (Jérôme Pugin).

Discussion.

Blockade of apoptosis as a rational therapeutic strategy for the treatment of sepsis (Alfred Ayala, Doreen E. Wesche-Soldato, Mario Perl, Joanne L. Lomas-Neira, Ryan Swan and Chun-Shiang Chung).

Discussion.

Modulating neutrophil apoptosis (John C. Marshall, Zeenat Malam and Songhui Jia).

Discussion.

HMGB1 as a potential therapeutic target(Haichao Wang, Wei Li, Richard Goldstein, Kevin J. Traceyand Andrew E. Sama).

Discussion.

Poly (ADP-ribose) polymerase activation and circulatory shock (Csaba Szabó).

Discussion.

Choosing the right substrate (Xavier Leverve, Cécile Batandier and Eric Fontaine).

Discussion.

Inhibiting glycogen synthase kinase 3β in sepsis (Laura Dugo, Marika Collin, David A. Allen, Nimesh S.A. Patel, Inge Bauer, Eero M. A. Mervaala, Marjut Louhelainen, Simon J. Foster, Muhammad M. Yaqoob and Christoph Thiemermann).

Discussion.

Ethyl pyruvate: a novel treatment for sepsis (Mitchell P. Fink).

Discussion.

General discussion I.

Cytoprotective and anti-inflammatory actions of carbon monoxide in organ injury and sepsis models(Stefan W. Ryter and Augustine M. K. Choi).

Discussion.

The hypothalamic pituitary adrenal axis in sepsis (Andrea Polito, Jérôme Aboab andDjillali Annane).

Discussion.

Modulating the endocrine response in sepsis: insulin and blood glucose control (Ilse Vanhorebeek, Lies Langouche and Greet Van den Berghe).

Discussion.

The neuronal strategy for inflammation(Luis Ulloaand Ping Wang).

Discussion.

Beta-blockade in burns (C. T. Pereira, M. G. Jeschke and D. N. Herndon).

Discussion.

System interactions (Mervyn Singer).

Discussion.

Protecting the permeability pore and mitochondrial biogenesis (C. A. Piantadosi, M. S. Carraway, D. W. Haden and H. B. Suliman).

Discussion.

Contributor Index.

Subject index.

Read More

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >